650dkk
0,6 %
Date:2024-03-27Time:16:59:00Latest report:Q4-2023List:First NorthTicker:VIRO
Market Cap:40 mdkkEnterprise Value:29 mdkkNet Sales:5,58 mdkkEarnings:-12,1 mdkkEmployees:0ISIN:DK0061030574

Ratios

10-year key figure history for ViroGates turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ViroGates with index and moving average MA50 and MA200.

Stockprice:6,50
MA50:7,78
MA200:14,04
Price/MA200:-55,8 %
RSI (14):31,9
Price/MA50:-20,3 %

Description

ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

Medical Equipment